Hematologic Improvement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematologic Improvement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematologic Improvement Today - Breaking & Trending Today

First-in-Class Investigational SX-682 Demonstrates Single-Agent Efficacy in Patients with Hypomethylating Agent Failure Myelodysplastic Syndromes

Published: December 9, 2022

/PRNewswire/ -- Syntrix Pharmaceuticals today announced results from a single-arm, open-label Phase 1 trial of single-agent SX-682, an investigational CXCR1/2...

Source: prnewswire.com

Related Topics:

United StatesDavid SallmanAaron SchulerJohn ZebalaH Lee Moffitt Cancer CenterSyntrix PharmaceuticalsAmerican Society Of HematologyResearch InstituteInternational Prognostic Scoring SystemNational HeartBlood InstitutePrnewswire Syntrix PharmaceuticalsOral SessionMeeting SupportPromising TargetPatients TreatedRecommended PhaseObjective ResponseHematologic ImprovementMoffitt Cancer CenterAmerican SocietyAnnual MeetingMyelodysplastic SyndromesHealth Care Amp HospitalsMedical Pharmaceuticals